2 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
Follow Sample Collection: new trials by email Literature Review of Sample Collection trials Research Report on Sample Collection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones Biospecimen Collection, Bone Scan, Computed Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2026-10-01 | 2026-08-28 | |
| Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study Biospecimen Collection, Ipilimumab, Nivolumab - Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2021-05-11 | 2026-06-10 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Central Nervous System Neoplasms (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Hematologic Neoplasms (1) · Lung Neoplasms (1) · Lymphoma (1) · Neuroblastoma (1) · Prostatic Neoplasms (1) · Turcot syndrome (1) · Xeroderma Pigmentosum (1)
National Cancer Institute (NCI) (2)
Canada (1) · United States (1)
Daniel A Morgenstern (1) · Zin W Myint (1)
P30CA015704 (1), UM1CA154967 (1), UM1CA186712 (1)